Nautilus Biotechnology Inc (NAUT NASDAQ) stock market data APIs
$1.3319
0.07(5.3%)
as of October 31, 2025
Try our APIs with
free plan!
Nautilus Biotechnology Inc Financial Data Overview
Price chart is built with
Anychart
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprising instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent probe binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers reagent kits, which include sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.
Prev. Close
1.3319
Open
1.3985
High
1.4442
Low
1.2679
52 wk Range
0.62-2.9181
Market Cap
168 M
Shares Outstanding
126 M
EPS
-0.11
Beta
1.328
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Nautilus Biotechnology Inc data using free add-ons & libraries
Get Nautilus Biotechnology Inc Fundamental Data
Nautilus Biotechnology Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -69 613 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-28
- EPS/Forecast: -0.15
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Nautilus Biotechnology Inc News
New
Nautilus (NAUT) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool. Date Tuesday, Oct. 28, 2025, at 8:30 a.m. ET Call participants Chief Executive Officer — Sujal PatelChief Marketing Officer — Kentaro SuzukiChief Financial Offic...
Nautilus (NAUT) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool. Date Tuesday, Oct. 28, 2025, at 8:30 a.m. ET Call participants Chief Executive Officer — Sujal Patel Chief Marketing Officer — Kentaro Suzuki Chief Financial Off...
Nautilus Biotechnology And 2 Other Promising Penny Stocks
As major U.S. stock indexes continue to set fresh records, investors are closely watching the Federal Reserve's latest moves and the potential impact on market trends. In this context, penny stocks—...
VTYX, MEDP, INBX Jump After Hours On Key Updates
(RTTNews) - Biotech stocks surged in after-hours trading on Wednesday, October 22, led by Ventyx Biosciences, which soared over 88% on positive Phase 2 data. A mix of earnings updates, clinical news, ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
